DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

JP Morgan Maintains Overweight on Kiniksa Pharmaceuticals, Raises Price Target to $24

JP Morgan maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Overweight and raises the price target from $22 to $24.

Benzinga · 03/11/2020 14:24

JP Morgan maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Overweight and raises the price target from $22 to $24.